Relentless Health Value cover image

EP448 (Part 1): 340B: Where It Started, Where It Is Now, and Who Is Really Benefiting From This Massive Program, With Shawn Gremminger

Relentless Health Value

00:00

The Transformation of the 340B Drug Pricing Program

This chapter examines the evolution of the 340B Drug Pricing Program from its inception targeting specific health facilities to its expansion accommodating a broader range of hospitals, particularly those serving low-income patients. It highlights the financial implications for healthcare systems as they leverage this program to increase profitability, often at the expense of independent practices and the intended beneficiaries. The discussion also emphasizes the lack of accountability regarding the use of funds generated through 340B, raising concerns about its effectiveness in supporting underserved communities.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app